Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INMT | O95050 | 4/20 | 1.00 |
| ▸ | USP2 | O75604 | 2/20 | 1.00 |
| ▸ | ACHE | P22303 | 6/20 | 0.38 |
| ▸ | NOS3 | P29474 | 4/20 | 0.36 |
| ▸ | NOS1 | P29475 | 4/20 | 0.36 |
| ▸ | NOS2 | P35228 | 4/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10601682 | 1.00 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL16583523 | 1.00 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL2401189 | 1.00 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL17417853 | 1.00 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL6853620 | 1.00 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL3047 | 1.00 | INMT (1.00) | INMTUSP2ACHENOS3NOS1 | |
| Iodide SCHEMBL23365018 | 0.98 | INMT (0.95) | INMTUSP2ACHENOS3NOS1 | |
| Ammonia Solution, Strong SCHEMBL6834929 | 0.98 | INMT (0.95) | INMTUSP2ACHENOS3NOS1 | |
| Bromide SCHEMBL8469764 | 0.98 | INMT (0.95) | INMTUSP2ACHENOS3NOS1 | |
| SCHEMBL2544511 | 0.98 | INMT (0.95) | INMTUSP2ACHENOS3NOS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2838934-A2 | MOSITURE CURABLE ORGANOPOLYSILOXANE COMPOSITION | Momentive Performance Materials Inc. (US) | 2015-02-25 | — | — | EP | claimed |
| US-20150038632-A1 | MOISTURE CURABLE ORGANOPOLYSILOXANE COMPOSITION | MOMENTIVE PERFORMANCE MATERIALS INC. | 2015-02-05 | — | — | US | claimed |
| WO-2013158236-A2 | MOSITURE CURABLE ORGANOPOLYSILOXANE COMPOSITION | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2013-10-24 | — | — | WO | claimed |
| EP-4731740-A1 | ALKALINE COMPOSITION, ITS USE AND A PROCESS FOR CLEANING SUBSTRATES COMPRISING COBALT AND COPPER | BASF SE (DE) | 2026-04-29 | — | — | EP | disclosed |
| US-20250346827-A1 | COMPOSITION, CLEANING METHOD OF SEMICONDUCTOR SUBSTRATE, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2025-11-13 | — | — | US | disclosed |
| US-12374540-B2 | Post-CMP semiconductor cleaning composition comprising an amine/alkanolamine mixture | FUJIFILM CORPORATION (JP) | 2025-07-29 | — | — | US | disclosed |
| EP-4569023-A1 | COMBINATION OF CATALYTIC COMPONENTS | PolyU GmbH (DE) | 2025-06-18 | — | — | EP | disclosed |
| US-12312569-B2 | Kit for cleaning agent and method for preparing cleaning agent | FUJIFILM CORPORATION (JP) | 2025-05-27 | — | — | US | disclosed |
| US-12247300-B2 | Cleaning solution and cleaning method | FUJIFILM CORPORATION (JP) | 2025-03-11 | — | — | US | disclosed |
| EP-4503093-A1 | COMPOSITION, AND PRODUCTION METHOD FOR SEMICONDUCTOR ELEMENT | FUJIFILM Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| WO-2024260812-A1 | ALKALINE COMPOSITION, ITS USE AND A PROCESS FOR CLEANING SUBSTRATES COMPRISING COBALT AND COPPER | BASF SE (DE) | 2024-12-26 | — | — | WO | disclosed |
| US-7745007-B2 | Release sheets and methods of making the same | S.D. WARREN COMPANY (US) | 2010-06-29 | — | — | US | disclosed |
| US-7745007-B2 | Release sheets and methods of making the same | S.D. WARREN COMPANY (US) | 2010-06-29 | — | — | US | disclosed |
| EP-2159641-A1 | SURFACE TREATMENT AGENT FOR FORMING PATTERN AND PATTERN FORMING METHOD USING THE TREATMENT AGENT | Fujifilm Corporation (JP) | 2010-03-03 | — | — | EP | disclosed |
| US-20080241742-A1 | SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
| US-20080241742-A1 | SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT | FUJIFILM CORPORATION (JP) | 2008-10-02 | — | — | US | disclosed |
| EP-1975718-A2 | Surface-treating agent for pattern formation and pattern-forming method using the surface-treating agent | FUJIFILM Corporation (JP) | 2008-10-01 | — | — | EP | disclosed |
| WO-2008055026-A2 | RELEASE SHEETS AND METHODS OF MAKING THE SAME | S.D. WARREN COMPANY (US) | 2008-05-08 | — | — | WO | disclosed |
| US-20080102271-A1 | Release sheets and methods of making the same | S.D. WARREN COMPANY | 2008-05-01 | — | — | US | disclosed |
| US-20080102271-A1 | Release sheets and methods of making the same | S.D. WARREN COMPANY | 2008-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080241742-A1 | SURFACE-TREATING AGENT FOR PATTERN FORMATION AND PATTERN-FORMING METHOD USING THE SURFACE-TREATING AGENT | KRT18, FSCN1, SLC11A2 | INMT 2950/4885USP2 1775/4885ACHE 1994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.